$23.430
-1.321 (-5.64%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de BCAX por análisis de gráficos similares
Alphio's BCAX stock price prediction model matches the current Bicara Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $23.74 (+1.32%). The 1-week path is $23.08 (-1.48%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Bicara Therapeutics Inc?
Bicara Therapeutics Inc is currently priced at $23.43, which is significantly below the average analyst price target of $39, indicating potential upside. However, the stock has an RSI of 34.91, suggesting it is oversold, and a forward P/E of 0, indicating no earnings growth expected in the near term. The company reported a net loss of $55.4 million in Q2 2026, which raises concerns about its financial health. Therefore, while there is potential for price appreciation, the ongoing losses and management changes present significant risks.
BCAX cerró en $23.43 el Friday, tras bajar -5.64%
Bicara Therapeutics Inc (BCAX) last closed at $23.43, losing -5.64%. These facts feed the 1-day and 1-week BCAX price prediction above.
Factores de la previsión
Los factores de la previsión de Bicara Therapeutics Inc (BCAX) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bullish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de BCAX, ordenadas por similitud.
Análisis de estacionalidad de BCAX
Historically the probability of a positive August return for BCAX is 48.78%. June offers the highest probability of a positive month at 51.22%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de BCAX
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Aug 2026 | $7.72 | $9.76 | $11.36 | -58.37% |
| Sep 2026 | $12.02 | $12.89 | $14.96 | -44.98% |
| Oct 2026 | $10.67 | $11.92 | $14.31 | -49.12% |
| Nov 2026 | $7.57 | $9.92 | $10.55 | -57.68% |
| Dec 2026 | $10.44 | $12.80 | $14.55 | -45.37% |
En 2026, se proyecta que Bicara Therapeutics Inc (BCAX) oscile entre $7.57 y $14.96.
Previsión mensual de Bicara Therapeutics Inc para 2026
En Aug de 2026, se proyecta que Bicara Therapeutics Inc promedie $9.76, con un mínimo de $7.72 y un máximo de $11.36.
En Sep de 2026, se proyecta que Bicara Therapeutics Inc promedie $12.89, con un mínimo de $12.02 y un máximo de $14.96.
En Oct de 2026, se proyecta que Bicara Therapeutics Inc promedie $11.92, con un mínimo de $10.67 y un máximo de $14.31.
En Nov de 2026, se proyecta que Bicara Therapeutics Inc promedie $9.92, con un mínimo de $7.57 y un máximo de $10.55.
En Dec de 2026, se proyecta que Bicara Therapeutics Inc promedie $12.80, con un mínimo de $10.44 y un máximo de $14.55.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.